This presentation provides an update on the results of the Angio-Seal Evolution Registry released by Dr. Robert J. Applegate during the 2009 Transcatheter Cardiovascular Therapeutics (TCT) convention in San Francisco, California.
Study goals: To assess the efficacy and safety of the Angio-Seal Evolution Device in patients undergoing routine cardiac catheterization and intervention via femoral artery access.